January 5, 2018

FDA: PharMEDium recalls 55 lots of compounded sterile drugs

By: Judy Mathias

Editor’s Note

The Food and Drug Administration on January 2 announced the recall by PharMEDium Services (Lake Forest, Illinois) of 55 lots (impacting 25,327 units) of compounded sterile drug products because of a lack of sterility assurance.

The recalled products were manufactured in PharMEDium’s Memphis location and distributed nationwide to hospitals and clinics.



Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

Upcoming Webinars
Live chat by BoldChat